Clomiphene

All congenital malformations (majors, minors, majors and minors, or unspecified)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S15758
R67024
Nehard, 2024 All congenital malformations (major and minor) (exclusion of chromosomal abnormalities or genetic defects) 1st trimester prospective cohort unexposed (general population or NOS) Adjustment: No Clomiphene exposure: Inadvertently during the first trimester of pregnancy (< 12 SA). Clomiphene indications: Inadvertently treated during pregnancy Matched 1.86 [0.95;3.63] C 13/262   29/1,062 42 262
ref
S15680
R65588
Weller, 2017 All major malformations preconceptional for kinetic reason retrospective cohort unexposed (general population or NOS) Adjustment: Yes Clomiphene exposure: 2 months before conception through the first month of pregnancy Clomiphene indications: Not detailled but exclusion of in vitro fertilization (IVF) treatments 1.12 [0.91;1.38] 126/1,861   5,962/98,728 6,088 1,861
ref
S15714
R65586
Banhidy, 2008 Congenital abnormality early pregnancy case control unexposed (general population or NOS) Adjustment: No Clomiphene exposure: Inadvertently during the first and second months of pregnancy. Clomiphene indications: Inadvertently treated during pregnancy Matched 1.17 [0.85;1.59] C 67/163   22,776/60,831 22,843 163
ref
S15812
R65138
Mili, 1991 Birth defects preconceptional for kinetic reason case control unexposed (general population or NOS) Adjustment: Yes Clomiphene exposure: 1 month before to 3 months after the date of conception Clomiphene indications: Any or not specified 0.97 [0.55;1.71] -/-   4,913/- - -
ref
Total 4 studies 1.15 [0.98;1.35] 28,973 2,286
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Nehard, 2024Nehard, 2024 1.86[0.95; 3.63]422626%ROB confusion: criticalROB selection: moderateROB classification: unclearROB missing: moderateROB mesure: criticalROB reporting: moderate Weller, 2017Weller, 2017 1.12[0.91; 1.38]6,0881,86160%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: unclearROB mesure: moderateROB reporting: critical Banhidy, 2008Banhidy, 2008 1.17[0.85; 1.59]22,84316326%ROB confusion: criticalROB selection: criticalROB classification: moderateROB missing: unclearROB mesure: unclearROB reporting: moderate Mili, 1991Mili, 1991 0.97[0.55; 1.71]--8%ROB confusion: criticalROB selection: criticalROB classification: unclearROB missing: unclearROB mesure: unclearROB reporting: critical Total (4 studies) I2 = 0% 1.15[0.98; 1.35]28,9732,2860.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.30[0.83; 2.05]6,1302,12350%NANehard, 2024 Weller, 2017 2 case control studiescase control studies 1.12[0.85; 1.47]22,8431630%NABanhidy, 2008 Mili, 1991 2 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.15[0.98; 1.35]28,9732,2860%NANehard, 2024 Weller, 2017 Banhidy, 2008 Mili, 1991 4 Tags Adjustment   - No  - No 1.34[0.88; 2.02]22,88542535%NANehard, 2024 Banhidy, 2008 2   - Yes  - Yes 1.10[0.91; 1.34]6,0881,8610%NAWeller, 2017 Mili, 1991 2 Clomiphene exposure   - 1 month before to 3 months after th ...  - 1 month before to 3 months after the date of conception 0.97[0.55; 1.71]-- -NAMili, 1991 1   - 2 months before conception through ...  - 2 months before conception through the first month of pregnancy 1.12[0.91; 1.38]6,0881,861 -NAWeller, 2017 1   - Inadvertently during the first and ...  - Inadvertently during the first and second months of pregnancy. 1.17[0.85; 1.59]22,843163 -NABanhidy, 2008 1   - Inadvertently during the first trim ...  - Inadvertently during the first trimester of pregnancy (< 12 SA). 1.86[0.95; 3.63]42262 -NANehard, 2024 1 Clomiphene indications   - Any or not specified  - Any or not specified 0.97[0.55; 1.71]-- -NAMili, 1991 1   - Inadvertently treated during pregnancy  - Inadvertently treated during pregnancy 1.34[0.88; 2.02]22,88542535%NANehard, 2024 Banhidy, 2008 2   - Not detailled but exclusion of in v ...  - Not detailled but exclusion of in vitro fertilization (IVF) treatments 1.12[0.91; 1.38]6,0881,861 -NAWeller, 2017 1 MatchedMatched 1.34[0.88; 2.02]22,88542535%NANehard, 2024 Banhidy, 2008 2 All studiesAll studies 1.15[0.98; 1.35]28,9732,2860%NANehard, 2024 Weller, 2017 Banhidy, 2008 Mili, 1991 40.25.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-0.80.90.4090.000Nehard, 2024Weller, 2017Banhidy, 2008Mili, 1991

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.15[0.98; 1.35]33,8772,2860%NANehard, 2024 Weller, 2017 Banhidy, 2008 Mili, 1991 40.510.01.0